A Patient Awareness Workshop on Orofacial Granulomatosis (OFG) & Inflammatory Bowel Disease (IBD) On Monday, 3rd March 2025, we hosted an insightful Patient Awareness Workshop in collaboration with University College London (UCL), bringing together patients, researchers, and clinicians to discuss Orofacial Granulomatosis (OFG) and its link to Inflammatory Bowel Disease (IBD). The session […]
How glycomics can be used to measure Chronic inflammation? Chronic inflammation is a major health concern worldwide, associated with numerous diseases, including cancer, cardiovascular disease, and diabetes. While inflammation is a natural response to injury or infection, persistent or chronic inflammation can lead to tissue damage and contribute to the development of various diseases. Recent
How glycomics can be used to measure Chronic inflammation? Read More »
Introduction to Avenna In this video, we explain how our in-vitro diagnostic platform technology- GlyHealth can enhance healthcare for chronic inflammatory diseases. We explain the benefits of our biomarkers for different members of healthcare ecosystem, including clinicians and drug development companies. BACK TO MEDIA GALLERY
Introduction to Avenna Read More »
Immunofraility Test. Instruction video In this video, we explain Avenna’s core technology, GlyHealth. We explain the current four variants in our development pipeline including, GlyHealth-Index, IBD, SCI, and COVID-19, and expand on GlyHealth-Index and IBD. This video also compares conventional vs glycomic biomarkers for early detection and treatment personalisation of inflammatory disease.
ImmunofrailityTest- Instruction video Read More »
